ATS 2026 showcased new pulmonary therapies, clinical trials, and cross-specialty collaboration to improve patient care.
Yet Khor, MD, PhD
Advertisement
Yet Khor, MD, PhD, is an associate professor in immunology research at Monash University.
Articles by Yet Khor, MD, PhD
Yet Khor, MD, PhD, discusses ILD care disparities, telehealth, trial awareness, and shared care strategies.
Yet Khor, MD, PhD, highlights diagnostic delays, language barriers, and inequities impacting ILD and PF care access.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Tec-Dara Demonstrates Superior 3-Year PFS vs Standard Therapy in Functional High-Risk Myeloma: Rahul Banerjee, MD
2
MRD-Guided CLL Treatment Duration: Personalization or Malpractice?
3
Global Hematology Trials Ensure Research Stays Applicable, Flexible, Patient-Centered
4
Blinatumomab Improves Outcomes, Toxicity in High-Risk Pediatric ALL: Martin Schrappe, MD, PhD
5